Professor, Pediatrics, University of Texas Southwestern Medical Center, Southwestern Medical School
Pediatric Hematology & Oncology
Dr. Naomi J. Winick, MD
|
|
Give Review
Naomi J. Winick, MD works in the field of Pediatric Hematology & Oncology. He studied medicine at Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine has a rank of 19 in research and a 29 in primary care He received 3 awards: "America's Top Doctors", "America's Top Doctors for Cancer" and "Super Doctor". Naomi Winick is a published MD. He has 46 publications published. The most current publication "MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: A children's oncology group study."
Publications
- MLL rearrangements impact outcome in HOXA-deregulated T-lineage Acute lymphoblastic leukemia: A children's oncology group study.
- CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.
- The evolution of central nervous system prophylaxis for patients with Acute lymphoblastic leukemia.
- Germline genetic variation in ETV6 and risk of childhood Acute lymphoblastic leukaemia: a systematic genetic study.
- Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia-Comparison among Different Treatment Strategies.
- Genetics of glucocorticoid-associated osteonecrosis in children with Acute lymphoblastic leukemia.
- Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell Acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434.
- Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with Acute lymphoblastic leukemia.
- Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol Escherichia coli L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Re...
- Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3).
- Decreased induction morbidity and mortality following modification to induction therapy in infants with Acute lymphoblastic leukemia enrolled on AALL0631: A report fro...
- Subclinical cardiotoxicity in childhood Cancer survivors exposed to very low dose anthracycline therapy.
- Family life events in the first year of Acute lymphoblastic leukemia therapy: A children's oncology group report.
- HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies.
- Dose Intensification of Methotrexate and Cytarabine During Intensified Continuation Chemotherapy for High-risk B-Precursor Acute Lymphoblastic Leukemia: POG 9406: A Re...
- Hyaluronan Synthase 3 Variant and Anthracycline-Related Cardiomyopathy: A Report From the Children's Oncology Group.
- Association of hospital construction with the development of healthcare associated environmental mold infections (HAEMI) in pediatric patients with Leukemia.
- Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive Acute lymphoblastic leukemia: Children's Oncology Group Study AALL0031.
- Philadelphia chromosome-negative very high-risk Acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031.
- A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood Acute lymphoblastic leukemia: A report from the Chi...
- Hearing loss and vestibular dysfunction among children with Cancer after receiving aminoglycosides.
- Inherited GATA3 variants are associated with Ph-like childhood Acute lymphoblastic leukemia and risk of relapse.
- Intrachromosomal Amplification of Chromosome 21 Is Associated With Inferior Outcomes in Children With Acute Lymphoblastic Leukemia Treated in Contemporary Standard-Ris...
- Invited reply to amikacin ototoxicity in children with Cancer: The problem is the administration schedule.
- Novel Susceptibility Variants at 10p12.31-12.2 for Childhood Acute Lymphoblastic Leukemia in Ethnically Diverse Populations.
- Genome-wide study of methotrexate clearance replicates SLCO1B1.
- Tyrosine kinome sequencing of pediatric Acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project.
- Polymorphisms in CYP1A1 and Ethnic-Specific Susceptibility to Acute Lymphoblastic Leukemia in Children.
- Multilocus Association of Genetic Variants in MLL, CREBBP, EP300, and TOP2A with Childhood Acute Lymphoblastic Leukemia in Hispanics from Texas.
- Candidate gene association analysis of Acute lymphoblastic leukemia identifies new susceptibility locus at 11p15 (LMO1).
- Ancestry and pharmacogenomics of relapse in Acute lymphoblastic leukemia.
- Plasma Methotrexate, Red Blood Cell Methotrexate, and Red Blood Cell Folate Values and Outcome in Children With Precursor B-Acute Lymphoblastic Leukemia: A Report From...
- Down syndrome childhood Acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Childre...
- Factors influencing survival after relapse from Acute lymphoblastic leukemia: a Children's Oncology Group study.
- Risk factors for readmission after initial diagnosis in children with Acute lymphoblastic leukemia.
- Reinduction platform for children with first marrow relapse of Acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
- Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
- Risk- and response-based classification of childhood B-precursor Acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Gr...
- Therapy of low-risk subsets of childhood Acute lymphoblastic leukemia: when do we say enough?
- Childhood Leukemia--new advances and challenges.
- Effects of intraventricular methotrexate on folate, adenosine, and homocysteine metabolism in cerebrospinal fluid.
- Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study.
- Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
- Methotrexate polyglutamation may lack prognostic significance in children with B-cell precursor Acute lymphoblastic leukemia treated with intensive oral methotrexate.
- Rapidly fatal Acute bacterial myocarditis in a nonneutropenic child with Acute lymphoblastic leukemia in remission.
Schools
Northwestern University The Feinberg School Of Medicine
Babies Hospital Colum Presby Me
Sloan Kettering Canc Center
Conditions Treated
- Acute Leukemia
- Anemia
- Lymphoma
- Neutropenia
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Choice
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Choice Care PPO
- Preferred PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Super Doctor
Education
-
Memorial Sloan-Kettering Cancer Center -
Medical College of Wisconsin Affiliated Hospitals -
New York Presbyterian Hospital - Columbia Campus -
Northwestern University Feinberg School of Medicine
Hospital
-
University of Texas Southwestern Medical Center -
Children's Health System of Texas
Helpful Reviews
Similar Doctors
|
|
Dr. Jason B. Litten, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen X. Skapek, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Vani Venkatachalam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ayesha N. Zia, MD
This Doctor is OpenDoctor Recommended.
|